how do glp 1 meds work Part of a 3-Part Series; GLP-1 Medications for Weight Loss What is GLP-1 and how

Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas

Can I see a mental health provider as part of my treatment

Administration of semaglutide at the dose regimen of ~ 90 g/kg/day failed to evidence significant weight loss but more importantly, led to alteration of cortical bone microarchitecture, represented by lower cortical thickness, and ultimately to a significant decrease in bone strength [69]

Mild nausea, reduced appetite, feeling full quickly, and some fatigue are all normal first-week symptoms that don't require immediate medical attention

Clinical guidelines support GLP-1 prescribing for individuals with a BMI of 30 or higher, or a BMI of 27 with weight-related conditions like hypertension or type 2 diabetes